Literature DB >> 28856536

Interleukin-8 and nuclear factor kappa B are increased and positively correlated in myelodysplastic syndrome.

Anacélia Gomes de Matos1,2,3, Howard Lopes Ribeiro Junior1,2,3, Daniela de Paula Borges1,2,3, Bruno Memória Okubo1,2, Juliana Cordeiro de Sousa1,2, Maritza Cavalcante Barbosa4, Marilena Facundo de Castro4, Romélia Pinheiro Gonçalves4, Ronald Feitosa Pinheiro5,6,7,8, Silvia Maria Meira Magalhães1,2,9,3.   

Abstract

The pathogenesis of myelodysplastic syndromes (MDS) is complex and depends on the interaction between aberrant hematopoietic cells and their microenvironment, probably including aberrations in cytokines and their signaling pathways. To evaluate interleukin-8 (IL-8) plasma levels and nuclear factor kappa B (NF-kB) in patients with MDS and to test possible correlation between IL-8 and NF-Kb, a total of 45 individuals were analyzed: 25 consecutive adult de novo MDS patients and 20 sex and age-matched healthy elderly volunteers. IL-8 analysis was performed by ELISA and activity of NF-kB by chemiluminescent assay. MDS patients showed higher level of IL-8 when compared to controls (p = 0.006). Patients aged 75 and above showed even higher levels (p = 0.035). NF-kB activity was significantly elevated in MDS patients when compared to controls (p < 0.0001) and higher in patients older than 75 years (p = 0.047). NF-kB activity was associated with higher serum ferritin (p = 0.042) and higher percentage of blasts (p = 0.028). A significant positive correlation between IL-8 and NF-kB was demonstrated (r = 0.480; p = 0.015). Many pathways involved in pathophysiology of MDS have been recently described, suggesting that an inflammatory process may act as a pathogenic driver. In this study, significantly elevated levels of IL-8 and NF-kB were demonstrated in MDS patients, with positive association of NF-kB with some markers of poor prognosis. A positive correlation between IL-8 and NF-kB suggests they cooperate as part of a complex networking of immune and inflammatory factors involved in MDS.

Entities:  

Keywords:  Interleukin-8 (IL-8); Myelodysplastic syndrome; Nuclear factor kappa B (NF-kB); Proinflammatory cytokine

Mesh:

Substances:

Year:  2017        PMID: 28856536     DOI: 10.1007/s12032-017-1023-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

1.  Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia.

Authors:  Steven M Kornblau; David McCue; Neera Singh; Wenjing Chen; Zeev Estrov; Kevin R Coombes
Journal:  Blood       Date:  2010-08-02       Impact factor: 22.113

2.  Myelodysplastic syndromes in South America: a multinational study of 1080 patients.

Authors:  Carolina B Belli; Ronald Feitosa Pinheiro; Yesica Bestach; Irene B Larripa; Roberta Sandra da Silva Tanizawa; Graciela Alfonso; Jacqueline Gonzalez; Mariana Rosenhain; Nora Watman; Marcela Cavalcante de Andrade Silva; Pedro Negri Aranguren; Hernán García Rivello; Silvia M M Magalhaes; Ximena Valladares; María S Undurraga; Elvira R P Velloso
Journal:  Am J Hematol       Date:  2015-09-10       Impact factor: 10.047

3.  The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia.

Authors:  Ashish Banerjee; Nicole A Mifsud; Robert Bird; Cecily Forsyth; Jeff Szer; Constantine Tam; Sybil Kellner; Andrew Grigg; Penelope Motum; Mark Bentley; Stephen Opat; George Grigoriadis
Journal:  Br J Haematol       Date:  2014-10-01       Impact factor: 6.998

4.  Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.

Authors:  Christina A Meyers; Maher Albitar; Elihu Estey
Journal:  Cancer       Date:  2005-08-15       Impact factor: 6.860

Review 5.  Inflammation meets cancer, with NF-κB as the matchmaker.

Authors:  Yinon Ben-Neriah; Michael Karin
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

Review 6.  The interleukin-8 pathway in cancer.

Authors:  David J J Waugh; Catherine Wilson
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

Review 7.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

8.  Autoimmunity and Inflammation in Myelodysplastic Syndromes.

Authors:  Ofir Wolach; Richard Stone
Journal:  Acta Haematol       Date:  2016-06-24       Impact factor: 2.195

Review 9.  Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.

Authors:  Jagdeep K Singh; Bruno M Simões; Sacha J Howell; Gillian Farnie; Robert B Clarke
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

Review 10.  Immune Mechanisms in Myelodysplastic Syndrome.

Authors:  Andreas Glenthøj; Andreas Due Ørskov; Jakob Werner Hansen; Sine Reker Hadrup; Casey O'Connell; Kirsten Grønbæk
Journal:  Int J Mol Sci       Date:  2016-06-15       Impact factor: 5.923

View more
  4 in total

1.  Immune Dysregulation and Recurring Mutations in Myelodysplastic Syndromes Pathogenesis.

Authors:  Anacélia Matos; Silvia M M Magalhães; Michael J Rauh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis.

Authors:  Xin Shi; Yanhua Zheng; Li Xu; Chun Cao; Baoxia Dong; Xiequn Chen
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 3.  Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review.

Authors:  Olivia F Lynch; Laura M Calvi
Journal:  Cells       Date:  2022-02-08       Impact factor: 6.600

4.  Photobiomodulation of oral fibroblasts stimulated with periodontal pathogens.

Authors:  H J Serrage; P R Cooper; W M Palin; P Horstman; M Hadis; M R Milward
Journal:  Lasers Med Sci       Date:  2021-05-15       Impact factor: 3.161

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.